Investing for Retirement: Quality Stocks
This is a news story, published by Yahoo Finance, that relates primarily to Gilead Sciences news.
stocks trading & speculation news
For more stocks trading & speculation news, you can click here:
more stocks trading & speculation newsYahoo Finance news
For more news from Yahoo Finance, you can click here:
more news from Yahoo FinanceAbout the Otherweb
Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about
Stocks Retirees. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest retirees news, Everything retirees news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
Many retireesThe Motley Fool
•Three of the best stocks to buy for retirees: AbbVie, Bristol Myers Squibb, and Gilead Sciences
71% Informative
Three Motley Fool contributors think they have found stocks to buy that retirees should absolutely love.
All three offer juicy dividend yields.
Gilead Sciences , AbbVie and Bristol Myers Squibb all offer reliable income and growth prospects.
The Motleys Fool contributors say they're looking for reliable, reliable companies that pay regular dividends.
Gilead Sciences has increased its payout by 22% in the past five years .
Its forward yield currently tops 4.15% .
Retirees -- and income seekers of all types -- can't go wrong with this pick, in my view.
The biotech's ability to innovate and patients won't be inclined to stop taking its medicines even when the economy is down.
VR Score
67
Informative language
67
Neutral language
46
Article tone
semi-formal
Language
English
Language complexity
42
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
detected
Known propaganda techniques
not detected
Time-value
medium-lived
External references
9
Source diversity
2
Affiliate links
no affiliate links